Yinghua Xu

Dr. Yinghua Xu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
JWJian Wang
Jian Wang
LSLiqian Su
Liqian Su
LZLun Zhang
Lun Zhang
JZJiali Zeng
Jiali Zeng
QCQingru Chen
Qingru Chen
XLXue-mei Lu
Xue-mei Lu
Ulcerative colitis (UC) is a chronic and recurrent inflammatory bowel disease (IBD) that has become a major gastroenterologic problem during recent decades

7 September 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
JWJian Wang
Jian Wang
LZLun Zhang
Lun Zhang
HXHui Xin
Hui Xin
YGYa Guo
Ya Guo
BZBaokang Zhu
Baokang Zhu
XLXue-mei Lu
Xue-mei Lu

2 November 2023 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
MGMing-Quan Guo
Ming-Quan Guo
YWYi-Ting Wang
Yi-Ting Wang
SWShan-Shan Wang
Shan-Shan Wang
LCLi-Kuang Chen
Li-Kuang Chen
YXYinghua Xu
Yinghua Xu
GLGang Li
Gang Li
Hypervirulent carbapenem-resistant Klebsiella pneumoniae (Hv-CRKP) triggered a significant public health challenge. This study explored the prevalence trends and key genetic characteristics of Hv-CRKP in one Shanghai suburbs hospital during 2014-2018. During five years, Hv-CRKP strains identified from 2579 CRKP by specific PCR, were subjected to performed short- and long-read sequencing technology; epidemiological characteristics, antimicrobial-resistance genes (ARGs), virulence determinants, detailed plasmid profiles and conjugation efficiency were comprehensively investigated. 155 Hv-CRKP and 31 non-Hv-CRKP strains were sequenced. Hv-CRKP strains exhibited significant resistance to six common antibiotic classes (>92%). ST11 steadily increased and became the most prevalent ST (85.2%), followed by ST15 (8.5%), ST65 (2.6%), ST23 (1.9%), and ST86 (0.6%). ST11-KL64 (65.2%) rapidly increased from 0 in 2014 to 93.9% in 2018. blaKPC-2 was the primary carbapenemase gene (97.4%). Other ARGs switched from aac(3)-IId to aadA2 in aminoglycoside and from sul1 to sul2 in sulfanilamide. The time-dated phylogenetic tree was divided into four independent evolutionary clades. Clade 1 and 3 strains were mostly limited in the ICU, whereas Clade 2 strains were distributed among multiple departments. Compared to ybt14 in ICEKp12 in Clade 1, Clade 3 strains harbored ybt9 in ICEKp3 and blaCTX-M-65. Hv-CRKP infected more wards than non-Hv-CRKP and showed greater transmission capacity. Three plasmids containing crucial carbapenemase genes demonstrated their early transmission across China. The Hv-CRKP ST11-KL64 has rapidly replaced ST11-KL47 and emerged as the predominant epidemic subtype in various hospital wards, highlighting the importance of conducting comprehensive early surveillance for Hv-CRKP, especially in respiratory infections.

21 July 2024 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
JGJing Guo
Jing Guo
Qi WANGQi WANG
Qi WANG
CCChunxia Chen
Chunxia Chen
CZChunfa Zhang
Chunfa Zhang
YXYinghua Xu
Yinghua Xu
SLSong Liu
Song Liu

30 January 2025 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
SWShanshan Wang
Shanshan Wang
BLBin Li
Bin Li
QCQiong Chen
Qiong Chen
CWChune Wang
Chune Wang
BWBin Wang
Bin Wang
YXYinghua Xu
Yinghua Xu
Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention. The PPV23 and PCV13 vaccines are available in the Chinese market and are primarily produced by domestic manufacturers. The potential risk of increased IPD caused by non-vaccine serotypes should be considered. Here, we review the current status of IPD, pneumococcal vaccines, and their quality control in China. We also address the challenges and future directions for making progress in controlling IPD, emphasizing the need for further evaluation of the disease burden and monitoring the effectiveness of vaccination efforts.

30 July 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BZBaokang Zhu
Baokang Zhu
HXHui Xin
Hui Xin
MYMusheng Yang
Musheng Yang
LPLingling Pan
Lingling Pan
XZXuan Zou
Xuan Zou
XLXue-mei Lu
Xue-mei Lu
Ventilator-associated pneumonia (VAP) is a common healthcare-acquired infection often arising during artificial ventilation using endotracheal intubation (ETT), which offers a platform for bacterial colonization and biofilm development. In particular, the effects of prolonged COVID-19 on the respiratory system. Herein, we developed an antimicrobial coating (FK-MEM@CMCO-CS) capable of visualizing pH changes based on bacterial infection and releasing meropenem (MEM) and FK13-a1 in a controlled manner. Using a simple dip-coating process with controlled loading, chitosan was cross-linked with sodium carboxymethyl cellulose oxidation (CMCO) and coated onto PVC-based ETT to form a hydrogel coating. Subsequently, the coated segments were immersed in an indicator solution containing bromothymol blue (BTB), MEM, and FK13-a1 to fabricate the FK-MEM@CMCO-CS coating. In vitro studies have shown that MEM and FK13-a1 can be released from coatings in a pH-responsive manner. Moreover, anti-biofilm and antibacterial adhesion results showed that FK-MEM@CMCO-CS coating significantly inhibited biofilm formation and prevented their colonization of the coating surface. In the VAP rat model, the coating inhibited bacterial growth, reduced lung inflammation, and had good biocompatibility. The coating can be applied to the entire ETT and has the potential for industrial production.